Last reviewed · How we verify

NCT02443610: HEMOTHEPP

Haemorrhages and Thromboembolic Venous Disease of the Postpartum

Completed Last updated 1 June 2023
What this trial tests

trial in Postpartum Hemorrhage in 20,241 participants. Completed in 27 April 2021.

Timeline
6 January 2015
Primary endpoint
27 April 2021
27 April 2021

Quick facts

Lead sponsorUniversity Hospital, Brest
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20,241
Start date6 January 2015
Primary completion27 April 2021
Estimated completion27 April 2021
Sites6 locations across France

Conditions studied

Sponsor

University Hospital, Brest

Who can join

16 and older, female only, with Postpartum Hemorrhage or Venous Thromboembolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the frequencey and the determinants of postpartum major complications (hemorrhage and thrombosis) up to 3 months after delivery in the maternity hospitals of Finistère (Bretagne - France)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Development and Validation of a Predictive Tool for Postpartum Hemorrhage after Vaginal Delivery: A Prospective Cohort Study.
    Bihan L, Nowak E, Anouilh F, Tremouilhac C, et al · · 2022 · cited 6× · PMID 36671746 · DOI 10.3390/biology12010054

Verify or expand the search:

Other recruiting trials for Postpartum Hemorrhage

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02443610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing